✦ LIBER ✦

Change in OTC status for asthma drugs

✍ Scribed by PaulM. Rowe

Book ID: 118554253
Publisher: The Lancet
Year: 1994
Tongue: English
Weight: 184 KB
Volume: 344
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(94)90306-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Workshop summary: Relating inflammatory

Workshop summary: Relating inflammatory changes in asthma to clinical status

✍ J. Bousquet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Changing profile in the use of anti-asth

Changing profile in the use of anti-asthma drugs

✍ H. M. Bell; J. C. McElnay; C. M. Hughes 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 3 views

Data regarding the total number of anti-asthma drugs dispensed via community pharmacies within Northern Ireland from 1980 to 1997 were collected and analysed. The use of anti-asthma drugs within this population increased markedly over the study period from 19.84 DDDs/1000/day to 84.07 DDDs/ 1000/day

New targets for drug development in asth

New targets for drug development in asthma

✍ Ian M Adcock; Gaetano Caramori; K Fan Chung 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 656 KB

Analysis of longitudinal changes in the

Analysis of longitudinal changes in the psychological status of patients with asthma

✍ Toru Oga; Koichi Nishimura; Mitsuhiro Tsukino; Susumu Sato; Takashi Hajiro; Mich 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Prescribing trends for anti-asthma drugs

Prescribing trends for anti-asthma drugs in Tasmania following the National Asthma Campaign

✍ G. A. Jacobson; G. M. Peterson 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Changes in asthma drug therapy costs for

Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.

✍ D.B. PRICE; R.H. BEN-JOSEPH; Q. ZHANG 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 159 KB